ArticleBlood advances2022

A clinical laboratory-developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia.

Stanley W K Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.